110 related articles for article (PubMed ID: 8547892)
1. Evaluation of the biodistribution and in vivo biochemistry of 99mTc-cysteine and 99/99mTc-cysteine complexes--a potential renal imaging agent.
Wang AY; Liu RS
Nucl Med Biol; 1995 Oct; 22(7):937-42. PubMed ID: 8547892
[TBL] [Abstract][Full Text] [Related]
2. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
3. Dicarboxylate diamide dimercaptide (N2S2) technetium-99m complexes: synthesis and biological evaluation as potential renal radiopharmaceuticals.
Canney DJ; Billings J; Francesconi LC; Guo YZ; Haggerty BS; Rheingold AL; Kung HF
J Med Chem; 1993 Apr; 36(8):1032-40. PubMed ID: 8478903
[TBL] [Abstract][Full Text] [Related]
4. New renal function imaging agents. I. Synthesis and biological characterization of a [99mTc]diaminomercapto(thio)ether (DAMTE).
Brandau W; Fischer S; Puskás C; Steinsträsser A; Kuhlmann L; Schober O
Nucl Med Biol; 1994 Nov; 21(8):1073-81. PubMed ID: 9234365
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and renal handling of 99mTc-labeled peptides.
Trejtnar F; Laznicek M; Laznickova A; Mather SJ
J Nucl Med; 2000 Jan; 41(1):177-82. PubMed ID: 10647621
[TBL] [Abstract][Full Text] [Related]
9. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.
He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT
Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812
[TBL] [Abstract][Full Text] [Related]
10. Preparation and biological behaviour of 99mTc-carbonyl and 99mTc-nitrido complexes of cysteine and some cysteine esters.
Bonnyman J
Nucl Med Biol; 1995 Oct; 22(7):943-8. PubMed ID: 8547893
[TBL] [Abstract][Full Text] [Related]
11. Preparation and biological characteristics of 99mTc-diol a renal agent.
Castanheira I; Sawas-Dimopoulou C; Paulo A; Neves M; Patricio L
Nucl Med Biol; 1993 Apr; 20(3):279-85. PubMed ID: 8485487
[TBL] [Abstract][Full Text] [Related]
12. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of the (99m)tc-complexes of L-cysteine acetyldiglycine (a hybrid of MAG3 and L,L-EC) and of L-beta-homocysteine acetyldiglycine.
Mang'era K; Vanbilloen H; Cleynhens B; de Groot T ; Bormans G; Verbruggen A; Verbeke K
Nucl Med Biol; 2000 Nov; 27(8):781-9. PubMed ID: 11150711
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
15. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Caglar M; Yarís N; Akyuz C
Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
[TBL] [Abstract][Full Text] [Related]
16. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-2GAM: a tracer for renal imaging.
Gianolli L; Dosio F; Matarrese M; Colombo F; Cutler C; Stepniak-Biniakiewicz D; Deutsch E; Savi A; Lucignani G; Fazio F
Nucl Med Biol; 1996 Nov; 23(8):927-33. PubMed ID: 9004280
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution and renal excretion of isomers of the cationic tracer, (99m)Tc diaminocyclohexane (DACH): biodistribution of cationic renal tracers.
Taylor A; Hansen L; Marzilli LG
Nucl Med Biol; 2001 Apr; 28(3):299-302. PubMed ID: 11323241
[TBL] [Abstract][Full Text] [Related]
20. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.
Yang DJ; Kim CG; Schechter NR; Azhdarinia A; Yu DF; Oh CS; Bryant JL; Won JJ; Kim EE; Podoloff DA
Radiology; 2003 Feb; 226(2):465-73. PubMed ID: 12563141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
